Page last updated: 2024-08-24

halofuginone and Fibrosis

halofuginone has been researched along with Fibrosis in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.13)	18.2507
2000's	17 (43.59)	29.6817
2010's	16 (41.03)	24.3611
2020's	4 (10.26)	2.80

Authors

Authors	Studies
Gill, J; Sharma, A	1
Barzilai-Tutsch, H; Genin, O; Halevy, O; Pines, M	1
Chatelain, B; Dirand, Z; Humbert, P; Isidoro, C; Lihoreau, T; Marty, P; Rolin, G; Secomandi, E; Senez, C; Tissot, M	1
Evans, P; Genin, O; Halevy, O; Mordechay, S; Pines, M; Smullen, S	1
Arabacilar, P; Bantscheff, M; Bao, W; Bergamini, G; Bernard, RE; Del Rosario, J; Eisennagel, SH; Faelth Savitski, M; Force, TL; Gatto, GJ; Guo, Y; Halsey, WS; Hu, E; Hughes, AM; Joberty, G; Kirkpatrick, RB; Lal, H; Livi, GP; Lu, Q; Nayal, M; Olzinski, AR; Platchek, MC; Qin, P; Qu, XA; Quaile, MP; Rajpal, DK; Roethke, T; Sathe, GM; Schnackenberg, CG; Willette, RN; Wright, F; Xie, W	1
Gao, Y; Luo, D; Luo, Y; Wang, Y; Xie, X	1
Evans, P; Genin, O; Halevy, O; Mordechay, S; Pines, M; Wellner, G	1
Li, H; Tian, Y; Wang, KJ; Wazir, R; Yue, X	1
Pines, M	1
Allen, J	1
Ayan, F; Aydogan, F; Carkman, S; Durak, H; Erzin, Y; Gonenc, M; Karatas, A; Paksoy, M; Uzun, H	1
Kim, YM; Koo, BS; Park, JY; Park, YH; Rha, KS; Yoon, YH	1
Anderson, JE; Genin, O; Hagai, Y; Halevy, O; Huebner, K; Jassal, DS; Nagler, A; Pines, M; Turgeman, T	1
Arredondo, M; Belton, RJ; Grudzien, MM; Low, PS; Manning, PC; Nowak, RA	1
Genin, O; Halevy, O; Iovanna, JL; Kawada, N; Nagler, A; Pines, M; Roffe, S; Yoshizato, K; Zion, O	1
Cekin, IE; Cincik, H; Doğru, S; Ertuğrul, EE; Güngör, A	1
Choudhuri, R; Cook, JA; Flanders, KC; Ishii, H; Mathias, A; Mitchell, JB; Sowers, AL	1
Genin, O; Honig, H; Kawada, N; Nagler, A; Pines, M; Spector, I	1
Biton, E; Genin, O; Halevy, O; Harel, M; Moshe, I; Nevo, Y; Pines, M; Reif, S; Turgeman, T	1
Larena-Avellaneda, A; Schmidt, K; Zeplin, PH	1
Halevy, O; Pines, M	1
Cetinel, Ş; Karadeniz Cerit, K; Karakoyun, B; Özkan, N; Tolga Dağli, E; Tuğtepe, H; Yeğen, BÇ; Yüksel, M	1
Chang, AA; Ewel, JM; Huang, CW; Nelson, EF; Yuan, C	1
Genin, O; Lavy, A; Nagler, A; Pines, M; Spector, I; Zilberstein, Y	1
Barzilai-Tutsch, H; Genin, O; Halevy, O; Levi, O; Moshe, I; Pima, Y; Pines, M	1
Ata, O; Calik, G; Calik, M; Esme, H; Yavas, C; Yavas, G	1
Bona, C; Kodera, T; McGaha, T; Phelps, R; Pines, M; Spiera, H	1
Nagler, A; Pines, M; Snyder, D; Yarkoni, S	1
Ali-El-Dein, B; Bazeed, M; Hafez, AT; Jaidane, M; Mohsen, T; Ounaies, A	1
Felici, A; Flanders, KC; Fujii, M; Javelaud, D; Mauviel, A; Mitchell, JB; Piek, E; Reiss, M; Roberts, AB; Russo, A; Samuni, AM; Sowers, A; Xavier, S; Yarkoni, S	1
Doğusoy, G; Gümüştaş, K; Ozçelik, MF; Pekmezci, S; Saribeyoğlu, K; Unal, E	1
Bruno, W; Heller, L; Klitzman, B; Levin, LS; Meade, R; Olbrich, KC	1
Benchetrit, S; Bernheim, J; Pines, M; Rashid, G; Rathaus, M; Yarkoni, S	1
Berber, U; Cekin, E; Cincik, H; Dogru, S; Ertuğrul, EE; Gungor, A; Poyrazoğlu, IE	1
Anderson, JE; Halevy, O; Huebner, KD; Jassal, DS; Pines, M	1
McLoon, LK	1
Knopov, V; Levi-Schaffer, F; Nagler, A; Pines, M; Slavin, S	1
Nagler, A; Pines, M	1
Alexiev, R; Domb, A; Genina, O; Inbar, J; Nagler, A; Ohana, M; Pines, M	1

Reviews

7 review(s) available for halofuginone and Fibrosis

Article	Year
Prospects of halofuginone as an antiprotozoal drug scaffold. Drug discovery today, 2022, Volume: 27, Issue:9 Topics: Animals; Antiprotozoal Agents; Fibrosis; Humans; Malaria; Piperidines; Quinazolinones	2022
The role of halofuginone in fibrosis: more to be explored? Journal of leukocyte biology, 2017, Volume: 102, Issue:6 Topics: Animals; Collagen; Extracellular Matrix Proteins; Fibrosis; Humans; Models, Biological; Piperidines; Quinazolinones; Th17 Cells	2017
Prevention of stricture recurrence following urethral endoscopic management: what do we have? Journal of endourology, 2014, Volume: 28, Issue:5 Topics: Animals; Anti-Bacterial Agents; Brachytherapy; Catheterization; Dilatation; Endoscopy; Fibrosis; Humans; Piperidines; Quinazolinones; Rats; Secondary Prevention; Steroids; Urethra; Urethral Stricture; Urinary Catheterization	2014
Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World journal of gastroenterology, 2014, Oct-28, Volume: 20, Issue:40 Topics: Animals; Antineoplastic Agents; Digestive System Diseases; Digestive System Neoplasms; Fibrosis; Gastrointestinal Agents; Gastrointestinal Tract; Humans; Piperidines; Quinazolinones; Regeneration; Signal Transduction	2014
Halofuginone and muscular dystrophy. Histology and histopathology, 2011, Volume: 26, Issue:1 Topics: Animals; Collagen; Fibrosis; Gene Expression Profiling; Humans; Mice; Mice, Inbred mdx; Models, Biological; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Animal; Phosphorylation; Piperidines; Quinazolinones; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta	2011
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:7 Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Collagen Type I; Fibrosis; Graft vs Host Disease; Humans; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic	2003
Halofuginone: a novel antifibrotic therapy. General pharmacology, 1998, Volume: 30, Issue:4 Topics: Animals; Collagen; Fibrosis; Humans; Liver Cirrhosis; Piperidines; Postoperative Complications; Protein Synthesis Inhibitors; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Skin; Tissue Adhesions	1998

Other Studies

32 other study(ies) available for halofuginone and Fibrosis

Article	Year
Early pathological signs in young dysf Neuromuscular disorders : NMD, 2020, Volume: 30, Issue:6 Topics: Animals; Disease Models, Animal; Dysferlin; Fibrosis; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Piperidines; Protein Synthesis Inhibitors; Quinazolinones	2020
Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 135 Topics: Actins; Adult; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type I; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Humans; Keloid; Male; Middle Aged; Myofibroblasts; Piperidines; Procollagen; Quinazolinones; Skin; Transforming Growth Factor beta1; Young Adult	2021
Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy. International journal of molecular sciences, 2021, Jun-30, Volume: 22, Issue:13 Topics: Animals; Disease Models, Animal; Fibrosis; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Piperidines; Quinazolinones	2021
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress. Journal of the American Heart Association, 2017, May-09, Volume: 6, Issue:5 Topics: Amino Acids; Amino Acyl-tRNA Synthetases; Animals; Autophagy; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fibrosis; Heart Failure; Humans; Hypertrophy, Left Ventricular; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Piperidines; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Quinazolinones; Stress, Physiological; Time Factors; Ventricular Function, Left; Ventricular Remodeling	2017
Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophy. Histology and histopathology, 2019, Volume: 34, Issue:7 Topics: Animals; Disease Models, Animal; Fibrillar Collagens; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phosphorylation; Piperidines; Quinazolinones; Signal Transduction; Smad3 Protein; Utrophin	2019
Response of an ovine laryngeal injury model to a novel fibrosis inhibitor. ANZ journal of surgery, 2017, Volume: 87, Issue:4 Topics: Administration, Oral; Administration, Topical; Animals; Collagen; Disease Models, Animal; Elastin; Fibrosis; Injections, Intralesional; Piperidines; Quinazolinones; Sheep; Treatment Outcome; Vocal Cords; Wound Healing	2017
The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis. The Journal of surgical research, 2008, Volume: 148, Issue:1 Topics: Amylases; Animals; Collagen Type I; Disease Models, Animal; Female; Fibrosis; Hyaluronic Acid; Lipase; Nitric Oxide; Pancreas; Pancreatic Diseases; Pancreatitis; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Wistar	2008
The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2008, Volume: 139, Issue:1 Topics: Animals; Disease Models, Animal; Fibrosis; Glottis; Injections, Intraperitoneal; Laryngostenosis; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rabbits; Random Allocation	2008
Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone. Neuromuscular disorders : NMD, 2008, Volume: 18, Issue:11 Topics: Age Factors; Animals; Blotting, Western; Cell Line; Cells, Cultured; Collagen; Diaphragm; Fibrosis; Immunohistochemistry; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Motor Activity; Muscles; Muscular Dystrophy, Animal; Myoblasts; Myocardium; Piperidines; Postural Balance; Protein Synthesis Inhibitors; Quinazolinones; Rotarod Performance Test; Smad3 Protein	2008
The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells. Fertility and sterility, 2010, Mar-01, Volume: 93, Issue:4 Topics: Apoptosis; Cell Proliferation; Collagen Type I; Collagen Type III; Female; Fibrosis; Growth Inhibitors; Humans; Leiomyoma; Myocytes, Smooth Muscle; Myometrium; Piperidines; Quinazolinones; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterine Neoplasms	2010
Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. Pancreas, 2009, Volume: 38, Issue:4 Topics: Animals; Blotting, Western; Cells, Cultured; Ceruletide; Collagen; Cytoglobin; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Globins; Immunohistochemistry; In Situ Hybridization; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Pancreas; Pancreatitis-Associated Proteins; Piperidines; Procollagen-Proline Dioxygenase; Protein Disulfide-Isomerases; Protein Synthesis Inhibitors; Proteins; Quinazolinones; Serum Response Factor; Signal Transduction; Smad3 Protein; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta	2009
Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009, Volume: 140, Issue:5 Topics: Administration, Topical; Animals; Fibrosis; Laryngostenosis; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric	2009
Halofuginone mediated protection against radiation-induced leg contracture. International journal of oncology, 2009, Volume: 35, Issue:2 Topics: Animals; Cell Line; Contracture; Female; Fibrosis; Humans; Leg; Mice; Mice, Inbred C3H; Piperidines; Protein Serine-Threonine Kinases; Quinazolinones; Radiotherapy; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta	2009
Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor development. Pancreas, 2010, Volume: 39, Issue:7 Topics: Animals; Cell Line, Tumor; Extracellular Matrix; Fibrosis; Humans; Male; Mice; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Pancreatic Stellate Cells; Piperidines; Quinazolinones; Transplantation, Heterologous	2010
Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice. Muscle & nerve, 2010, Volume: 42, Issue:2 Topics: Animals; Cell Count; Cell Proliferation; Collagen; Fibrosis; Laminin; Mice; Mice, Knockout; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Animal; Piperidines; Quinazolinones; Rotarod Performance Test	2010
Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis. Plastic and reconstructive surgery, 2010, Volume: 126, Issue:1 Topics: Animals; Breast Implants; Coated Materials, Biocompatible; Collagen Type I; Disease Models, Animal; Female; Fibrosis; Foreign-Body Reaction; Mammary Glands, Animal; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Sprague-Dawley; Silicon; Treatment Outcome	2010
The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats. Journal of pediatric urology, 2013, Volume: 9, Issue:2 Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fibrosis; Glutathione; Kidney Diseases; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Nephrectomy; Oxidative Stress; Peroxidase; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Wistar; Reperfusion Injury	2013
Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts. Molecular vision, 2012, Volume: 18 Topics: Actins; Biomarkers; Cell Survival; Cells, Cultured; Collagen Type I; Cornea; Dose-Response Relationship, Drug; Fibroblasts; Fibronectins; Fibrosis; Gene Expression Regulation; Humans; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1	2012
Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice. PloS one, 2012, Volume: 7, Issue:7 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Ceruletide; Collagen; Extracellular Matrix; Fibrosis; Humans; Male; Mice; Mice, Transgenic; Myofibroblasts; Neoplasm Invasiveness; Pancreatic Neoplasms; Piperidines; Quinazolinones; Stromal Cells	2012
Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone. Histology and histopathology, 2013, Volume: 28, Issue:2 Topics: Animals; Collagen; Disease Models, Animal; Dysferlin; Fibrosis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Phosphorylation; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Smad3 Protein; Treatment Outcome	2013
The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis. Medical hypotheses, 2013, Volume: 80, Issue:4 Topics: Animals; Fibrosis; Humans; Lung Injury; Piperidines; Quinazolinones; Radiation Pneumonitis; Radiation-Protective Agents; Transforming Growth Factor beta	2013
Effect of halofuginone on the development of tight skin (TSK) syndrome. Autoimmunity, 2002, Volume: 35, Issue:4 Topics: Animals; Animals, Newborn; Collagen; Disease Models, Animal; Fibrosis; Humans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic; Skin Diseases	2002
The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits. The Journal of urology, 2003, Volume: 170, Issue:5 Topics: Administration, Oral; Animals; Electrocoagulation; Fibrosis; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rabbits; Secondary Prevention; Urethra; Urethral Stricture	2003
Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. The Journal of biological chemistry, 2004, Apr-09, Volume: 279, Issue:15 Topics: Animals; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cells, Cultured; COS Cells; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Fibrosis; Gene Deletion; Genes, Reporter; Humans; Immunoblotting; MAP Kinase Signaling System; Mice; Mice, Inbred C3H; Microscopy, Confocal; Microscopy, Fluorescence; Piperidines; Plasmids; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Radiation Pneumonitis; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad3 Protein; Time Factors; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury. American journal of surgery, 2004, Volume: 187, Issue:2 Topics: Animals; Burns, Chemical; Caustics; Collagen Type I; Esophageal Stenosis; Esophagus; Fibrosis; Injections, Intraperitoneal; Male; Models, Animal; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Sodium Hydroxide	2004
Halofuginone inhibits collagen deposition in fibrous capsules around implants. Annals of plastic surgery, 2005, Volume: 54, Issue:3 Topics: Animals; Collagen Type I; Colorimetry; Fibrosis; Male; Muscles; Piperidines; Prostheses and Implants; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Silicone Elastomers; Subcutaneous Tissue; Transforming Growth Factor beta	2005
Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats. The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:1 Topics: Animals; Blood Pressure; Case-Control Studies; Disease Models, Animal; Fibrosis; Kidney; Male; Nephrectomy; Piperidines; Protein Synthesis Inhibitors; Proteinuria; Quinazolinones; Rats; Rats, Wistar	2007
Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma. The Laryngoscope, 2007, Volume: 117, Issue:2 Topics: Animals; Cicatrix; Epithelium; Female; Fibrosis; Glottis; Injections, Intraperitoneal; Laryngitis; Laryngostenosis; Larynx; Male; Necrosis; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Random Allocation; Rats; Rats, Sprague-Dawley	2007
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4 Topics: Actins; Age Factors; Animals; Cell Proliferation; Collagen Type I; Collagen Type III; Diaphragm; Disease Models, Animal; Fibrosis; Heart; Hepatocyte Growth Factor; Mice; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Physical Endurance; Piperidines; Protein Synthesis Inhibitors; Quadriceps Muscle; Quinazolinones; Respiratory Mechanics; Running; Time Factors; Ventricular Function, Left	2008
Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4 Topics: Age Factors; Animals; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Heart; Mice; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardium; Physical Endurance; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Respiratory Mechanics; Time Factors; Ventricular Function, Left	2008
Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. The Journal of investigative dermatology, 1996, Volume: 106, Issue:1 Topics: Animals; Collagen; Disease Models, Animal; Fibrosis; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Osmolar Concentration; Piperidines; Quinazolines; Quinazolinones; Scleroderma, Localized; Skin	1996
Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone. Biochemical pharmacology, 2001, Nov-01, Volume: 62, Issue:9 Topics: Administration, Topical; Animals; Cell Division; Collagen; Disease Models, Animal; Fibrosis; Male; Mast Cells; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Skin	2001